XXII GEIS International Symposium

PROGRAM - download

FRYDAY 4th October 2024

9:00-9:10 WELCOME & INTRODUCTION

Antonio Álvarez Blanco, Hospital Clínico San Carlos, Madrid
Antonio Casado, Hospital Clínico San Carlos, Madrid
Gloria Marquina, Hospital Clínico San Carlos, Madrid
Claudia Valverde, University Hospital Vall d'Hebron, Barcelona

.

9:10-9:45 SESSION 1. FOCUSING ON OUR RESEARCHERS: AN OVERVIEW OF GEIS-BUESA GRANTS

9:15-9:25 And the winner is…
By Miquel Tarón.

9:25-9:30 Buesa 2024: new award.

9:30-9:40 Buesa 2022.
César Serrano team: Claudia Valverde. H Universitario Vall d'Hebrón. Barcelona

.

9:40-10:40 SESSION 2. SARCOMA SUBTYPE HIGHLIGHTED: TENOSYNOVIAL GIANT CELL TUMOR

Chairs: Lydia Mediavilla, Hospital General Universitario Gregorio Marañón, Madrid
           Javier Martínez Trufero, University Hospital Miguel Servet, Zaragoza

9:45-9:55. Interactive clinical case.
Laura Jiménez, ICO Bellvitge, Barcelona

9:55-10:05 Pathology insights.
Empar Mayordomo, Hospital Universitari i Politècnic La Fe, Valencia

10:05-10:15 What's the role of surgery?
Eduardo Ortiz, Hospital Universitario La Paz, Madrid

10:15-10:25 New treatment opportunities.
William Tap, Memorial Sloan Kettering Cancer Center, New York (New York), USA

10:25-10:40 Discussion

.

10:40-11:00 COFFEE BREAK

.

11:00-12:15 SESSION 3. LET’S IMPROVE: AYAS

Chairs: Cristina Mata, Hospital General Universitario Gregorio Marañón, Madrid
           Javier Orcajo, Hospital General Universitario Gregorio Marañón, Madrid

11:05-11:15 AYAs: why are they different?
Lianne Haveman, Prinses Máxima Centrum, Utrecht, The Netherlands

11:15-11:25 AYAs unit: what you need to start.
                         Macarena González & Paula Pérez, Vall d'Hebron University Hospital, Barcelona

11:25-11:35 Research: Trespassing the age barrier with ACCELERATE.
                        Cristina Larrossa, Hospital Sant Joan de Déu, Esplugues de Llobregat (Barcelona)

11:35-11:45 Networking: EUROEWING CONSORTIUM. What we have learned.
Sandra Strauss, University College London, London (United Kingdom)

11:45-11:55 There is no place like home.
Hilde Bøgseth, Oslo University Hospital, Oslo (Norway)

11:55-12:15 Discussion.

.

12:15-13:00 SESSION 4. FOCUSING ON IMMUNOTHERAPY

Chairs: Fina Cruz, Hospital Universitario de Canarias 
           José Alejandro Pérez Fidalgo, Hospital Clínico Universitario, Valencia

12:20-12:35 New approaches in other tumors.
Arjún Oberoi, Vall d'Hebron University Hospital, Barcelona.

12:35-12:50 Cell therapy in Ewing sarcoma.
                         Francesca Del Bufalo, Ospedale Pediatrico Bambino Gesù, Rome (Italy)

12:50-13:10 Discussion

.

13:15-14:00: LUNCH BREAK

.

14:00-15:00 SESSION 5. ARE WE READY FOR DIFFERENT TREATMENTS?

Chairs: José Manuel Morales, Hospital Univ. Virgen del Rocío, Seville
           Nadia Hindi, Hospital Universitario Fundación Jiménez Díaz, Madrid

14:05-14:15 Cryotheray. Indications and experience
Xavier Buy, Institute Bergonie, Bordeaux, France

14:15-14:25 Oncothermia. Indications and experience.
Elisabeth Arrojo, INMOA, Madrid

14:25-14:35 Discussion

14:35-14:45 GIST: Robotic assistance in difficult locations.
Sandra Castro, Hospital Universitario Vall d'Hebrón. Barcelona

14:45-14:55 WD-Liposarcoma: is medical treatment an option?
Robert Maki, Memorial Sloan-Kettering Cancer Center in New York, (New York), USA

14:55-15:15 Discussion.

.

15:15-17:00 SESSION 6. CHALLENGING ISSUES

Chairs: Iñigo San Miguel, Hospital Universitario Cruces, Baracaldo (Vizcaya)
           Javier Martín Broto, Hospital Universitario Fundación Jiménez Díaz, Madrid
           José Manuel Asencio, Hospital General Universitario Gregorio Marañón, Madrid

15:20-15:30 Pathological entities outside WHO? Clinical case.
  Luis Ortega, Hospital Clínico San Carlos, Madrid

15:30-15:40 Pathological insight. Paolo dei Tos.
University of Padua, Padua (Italy)

15:40-15:50 The Oncologist point of view.
Shreyas Patel, MD Anderson Cancer Center, Houston (Texas), USA

15:50-16:10 Discussion.

.

16:00-16:30 Coffee break

16:30-16:40 “Uncomfortable” locations: Axial skeleton. Are we ready? Clinical case + first vote.
Irene Carrasco, Hospital Univ. Virgen del Rocío, Sevilla

16:40-16:50 The surgeon point of view.
Antonio Martín Benlloch, Dr. Peset University Hospital, Valencia

16:50-17:00 The Radiation Oncologist point of view.
Felipe Calvo, Clínica Universitaria de Navarra, Madrid

17:00-17:10 The Oncologist point of view.
Miguel Abreum Portuguese Institute of Oncology of Porto, Porto (Portugal)

17:10-17:20 Discussion

.

17:20-18:30 SESSION 7. THE PATIENT ́S VOICE

Chairs: Rosa Alvarez & Ma Angeles Sala

The importance of supportive treatment
17:25-17:35 A patient challenge. Miguel Angel Rubio.
17:35-17:45 Nutritional assessment. Elena Roura. Fundación Alicia. Barcelona
17:45-17:55 Pre-rehabilitation and exercise. Oscar Martínez Sánchez. Fundación Ricky Rubio. Barcelona.
17:55-18:05 Taking care of the caregiver. Jonathan Levit, Escuela de Cuidadores de Fundación "la Caixa", Barcelona
18:05-18:30  Discussion.

Discussants: Patients representatives VYDA, FMPJC, APSATUR, ASARGA, Asociación IKER, FEPNC

.

18:30-18:40 FAREWELL

Antonio Casado, Hospital Clínico San Carlos, Madrid
Gloria Marquina, Hospital Clínico San Carlos, Madrid
Claudia Valverde, Vall d'Hebron University Hospital, Barcelona

.

.

VENUE

HOSPITAL CLÍNICO SAN CARLOS
C/ Manuel Bartolomé Cossío, s/n,
28040 Madrid

DINNER

3rd OCTOBER
CONFIRMATION REQUIRED

REGISTRATIONS

• Before July, 15th: 330,58€ + 21% (Spanish VAT) = 400€

• From 15th July to September, 1st: 454,55€ + 21% (Spanish VAT) = 550€

• After September, 1st: 578,51€ + 21% (Spanish VAT) = 700€

SYMPOSIUM SECRETARIAT

www.grupogeis.org

This email address is being protected from spambots. You need JavaScript enabled to view it.

.

.

SPONSORS:

LOGOS XXII SYMPOSIUM 1

UNDER THE AUSPICES OF:

LOGOS XXII SYMPOSIUM 2